Azathioprine transport through rat skin and its immunosuppressive effect

Pharmazie

Volumn 59, Issue 2, 2004, Pages 143-146

  Tashtoush, B M ^a   Al Safi, S A ^a   Al Fanek, K J ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DIMETHYL SULFOXIDE; MERCAPTOPURINE; N,N DIMETHYLFORMAMIDE;

ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; DRUG ABSORPTION; DRUG EFFECT; DRUG METABOLISM; DRUG PENETRATION; DRUG TRANSPORT; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; ORGAN TRANSPLANTATION; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN PENETRATION; STEADY STATE;

6-MERCAPTOPURINE; ALGORITHMS; ANIMALS; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENTS; PERMEABILITY; RATS; SKIN; SKIN ABSORPTION;

EID: 1242336906     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Austin HA, Balow JE (2000) Treatment of lupus nephritis. Semin Nephrol 20: 265-276.
2. Balow JE, Austin HA (2000) Progress in the treatment of proliferative lupus nephritis. Curr Opin Nephrol Hypertens 9: 107-155.
3. Biancone L, Pallone F (1999) Current treatment modalities in active Crohn's disease. Ital J Gastroenterol Hepatol 31: 508-514.
4. Baughman RP, Lower EE (1997) Steroid-sparing alternative treatments for sarcoidosis. Clin Chest Med 18: 853-864.
5. Case JP (2001) Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs. Am J Ther 8: 123-143.
6. Calne RY (1982) The initial study of the immunosuppressive effects of mercaptopurine and azathioprine in organ transplantation and a few words on cycloporine A. World of Surgery 6: 637-640.
7. Chi SC, Park ES, Kim H (1995) Effect of penetration enhancers on flurbiprofen permeation through rat skin. Int J Pharm 126: 267-274.
8. Cochat P, Schell M, Ranchin B, Boueva A, Said MH (1996) Management of recurrent nephrotic syndrome after kidney transplantation in children. Clin Nephrol 46: 17-20.
9. De Miranda P, Chu L (1970) Reaction of azathioprine (Imuran) with 14C glycine in the rat. Fed Proc 28: 608.
10. Dutz JP, Ho VC (1998) Immunosuppressive agents in dermatology. An update. Dermatol Clin 16: 235-251
11. Egan J (1998) Pharmacologic therapy of idiopathic pulmonary fibrosis. J Heart Lung Transplant 17: 1039-1044.
12. Elion GB, Hitchings GH (1975) Azathioprine. In: Handbook of experimental pharmacology Vol 38: 404-425.
13. Elion GB (1972) Significance of azathioprine metabolites. Proc R Soc Med 65: 257-259.
14. Epstein JB, Gorsky M, Epstein MS (2001) Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 56-61.
15. Foss PRB, Benezra SA (1978) In Florey K (ed) "Analytical profiles of Drug Substances", Vol 7; Academic Press: New York, p. 355.
16. Godwin DA, Player MR, Sowell JW, Michniak BB, (1998) Synthesis and investigation of urea compounds as transdermal penetration enhancers. Int J Pharm 167: 165-175.
17. Han SK, Jun YH, Rho YJ, Hong SC, Kim YM (1991) Percutaneous absorption-enhancing activity, of urea derivatives. Arch Pharm Res 14: 12-18.
18. Hay FC, Westwood OMR (2002) Immunological manipulations in vivo. In: Practical Immunology; Fourth ed. Blackwell Science, Oxford, p. 326-333.
19. Hoffmann M, Rychlewski J, Chrzanowska M, Hermann T (2000) Mechanism of activation of an immunosuppressive drug: azathioprine. Quantum chemical study on the reaction of azathioprine with cysteine. J Am Chem Soc 123: 6404-6409.
20. Hoffmann JC, Zeitz M (2000) Treatment of Crohn's disease. Hepatogastroenterology 47: 90-100.
21. Kaplowitz N (1977) Interaction of azathioprine and glutathione in the liver of the rat. J Pharmacol Exp Ther 200: 479-486.
22. Klamerus K, Lee G (1992) Effects of some hydrophilic permeation enhancers on the absorption of bepridil through excised human skin. Drug Dev Ind Pharm 18: 1411-1422.
23. Lashmar UT, Hadgraft J, Thomas N (1989) Topical application of penetration enhancers to the skin of nude mice: a histopathological study. J Pharm Pharmacol 41: 118-122.
24. Lawson DH, Lovatt GE, Gurton CS, Hennings RC (1984) Adverse effects of azathioprine. Adverse Drug React Acute Poisoning Rev 3: 161-171.
25. Lennard L (1992) The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 43: 329-339.
26. Locatelli F, Del Vecchio L, Pozzi C (1999) The patient with IgA glomerulonephritis-what is the role of steroid treatment. Nephrol Dial Transplant 14: 1057-1060.
27. Louis E, Belaiche J (1999) Treatment of inflammatory bowel disease with azathioprine: how to use it in 1999. Acta Gastroenterol Belg. 62: 437-439.
28. Ludwig D, Stange EF (2000) Treatment of ulcerative colitis. Hepatogastroenterology 47: 83-89.
29. Marbet U, Schmid I (2001) Severe life-threatening diarrhea caused by azathioprine but not 6-mercaptopurine. Digestion 63: 139-142.
30. Meggitt SJ, Reynolds NJ (2001) Azathioprine for atopic dermatitis. Clin Exp Dermatol 26: 369-375.
31. Nice LP (1998) Recognition and treatment of idiopathic pulmonary fibrosis. Drugs 55: 555-562.
32. Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14: 158-166.
33. Nouh AT, Ramadan E, El-Gawad AH (1989) Percutaneous absorption of azapropazone in rabbits. Pharm Ind 51: 1054-1056.
34. van Scoik KG, Johnson CA, Porter UR (1985) The pharmacology and metabolism of the thiopurine drugs 6-mescaptopurine and azathioprine. Drug Metab Rev 16: 157-174.
35. Sherlock S (1986) The spectrum of hepatotoxicity due to drugs. Lancet ii: 440-444.
36. Shoker AS (1996) Immunopharmacologic therapy in renal transplantation. Pharmacotherapy 16: 562-575.
37. Selroos O (1994) Treatment of sarcoidosis. Sarcoidosis 11: 80-83.
38. Snow JL, Gibson LE (1995) A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients. J Am Acad Dermatol 32: 114-116.
39. Uppal SS (1999) Treatment and outcome of lupus nephritis at the turn of the millennium. J Assoc Physicians India 47: 857-861.
40. Vaddi HK, Wang LZ, Ho PC, Chan SY (2001) Effect of some enhancers on the permeation of haloperidol through rat skin in vitro. Int J Pharm 16: 212: 247-255.
41. Williams AC, Barry BW (1989) Urea analogues in propylene glycol as penetration enhancers in human skin. Int J Pharm 36: 43-50.
42. Xu GQ, Xi NZ, Chen GS, Jiang XG, Xu HN (1991) Effect of enhancers on the cutaneous permeation of piroxicam in vitro. Zhongguo Yao Li Xue Bao 12: 235-238.